resources

press releases

IDRI in the news

hot topics

blog

reports

videos

publications

  view by category

  view by date


Press Releases

2014

IDRI Named "Outstanding Global Health Organization" by WGHA
Seattle, WA | August 21, 2014

IDRI'S Rhea Coler Recognized as Recipient of "Women to Watch in Life Science" Award
Seattle, WA | June 10, 2014

IDRI Receives $3.4 Million Grant Extension for TB Drug Discovery
Seattle, WA | March 24, 2014

2013

IDRI Announces Evolution of Leadership Roles
Seattle, WA | December 19, 2013

IDRI and Zydus Sign Agreement for Development of IDRI’s Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar)
Seattle, WA | July 25, 2013

IDRI Moves Into New Space At 1616 Eastlake
Seattle, WA | May 7, 2013

IDRI and Medicago Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
Seattle, WA | April 17, 2013

IDRI and Medicago to Present Data at the World Vaccine Congress
Seattle, WA | April 8, 2013

IDRI and Orangelife Register Rapid Diagnostic for Leprosy for Use in Brazil
Seattle, WA | January 24, 2013

2012

TB Vaccine Candidate Enters Clinical Testing
Seattle, WA | August 22, 2012

IDRI and Medicago Authorized to Initiate Trial for an H5N1 Vaccine
Seattle, WA | August 16, 2012

IDRI Receives $3.7 Million Grant for TB Drug Discovery
Seattle, WA | July 25, 2012

IDRI Expands Board, Adding Additional International Expertise
Seattle, WA | July 2, 2012

Seven Pharmaceutical Companies Join Academic Researchers to Speed TB Drug Discovery
Seattle, WA | June 25, 2012

Clinical Trial of Human Hookworm Vaccine Begins at Children's National Medical Center
Washington, DC | June 13, 2012

IDRI Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters
Seattle, WA | May 30, 2012

AERAS and IDRI Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine
Rockville, MD | Seattle, WA | May 9, 2012

IDRI Quest for Leprosy Vaccine Closer to Reality with Help of Million Dollar Grant
Seattle, WA | March 8, 2012

First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial
Seattle, WA | February 22, 2012

IDRI Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial
Seattle, WA | January 31, 2012

IDRI Awarded Additional Funds for Novel TB Drugs
Seattle, WA | January 11, 2012

2011

Human trials initiated for new HIV vaccine
Seattle, WA | December 21, 2011

IDRI Announces New VP Tuberculosis Drug Development: Gail H. Cassell, PhD, to Join IDRI
Seattle, WA | December 7, 2011

IDRI to Present at India - US Forum: Dr. Christopher Fox to Discuss IDRI's Technology Transfer Efforts
Seattle, WA | November 29, 2011

Eli Lilly and Company Provides IDRI with Additional Funding for Identification of New Tuberculosis Therapies
Seattle, WA | November 17, 2011

IDRI Partners with Global Research Initiative ADITEC to Accelerate Human Vaccine Development
Seattle, WA | October 17, 2011

The Paul G. Allen Family Foundation Supports Launch of IDRI's TB Vaccine Clinical Program
Seattle, WA | October 12, 2011

GlaxoSmithKline Donates Scientific Equpment to Advance IDRI's Global Health Mission
Seattle, WA | October 3, 2011

IDRI Launches New and Improved Website
Seattle, WA | September 7, 2011

IDRI, USAID Strike New Collaboration for Malaria Vaccine Development
Seattle, WA | August 16, 2011

IDRI Announces New EVP Business Development & External Affairs
Seattle, WA | August 2, 2011

IDRI Announces Appointment of H. Stewart Parker as Chief Executive Officer
Seattle, WA | February 15, 2011

IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs
Seattle, WA | January 14, 2011

IDRI Receives DARPA Grant to Develop a Novel Vaccine to Combat Pandemic Flu
Seattle,WA | January 7, 2011

2010

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza
Seattle, WA | December 3, 2010

IDRI Awarded $790,200 Grant from US Government to Develop Pandemic Flu Vaccine With Cantacuzino Institute
Seattle, WA | December 3, 2010

IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports
Seattle, WA | October 14, 2010


IDRI and Merial Enter into Research Collaboration
Seattle, WA | Duluth, GA | July 14, 2010

2009

The Lilly TB Drug Discovery Initiative Announces New Collaborator
Seattle, September 29, 2009

IDRI Initiates Therapeutic Vaccine Clinical Trial in Sudan Against Leishmaniasis
Seattle, WA | Aug 27, 2009

IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests
Seattle, WA | Nes Ziona, Israel | August 31, 2009

IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program
Seattle | June 25, 2009

IDRI Makes its Adjuvant Available to Increase Global Supply of Pandemic Vaccines
Seattle, WA | June 11, 2009

Global Health Research to Push for More U.S. Support: Dr. Steve Reed has been named Global Health Research Ambassador
Seattle, WA | January 14, 2009

2008

IDRI Awarded $7 Million Grant from the Bill & Melinda Gates Foundation to Fight Visceral Leishmaniasis in Africa
Seattle, WA | December 18, 2008

IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
Seattle, WA | November 20, 2008

IDRI Receives NIH Funding to Design Adjuvants to Improve New TB Vaccine Protection
Seattle, WA | August 26, 2008

3M Collaborates with Infectious Disease Research Institute on Vaccine Adjuvants
St. Paul, MN | May 1, 2008

New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
Seattle, WA | January 30, 2008

2007

Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
Seattle, WA | December 4, 2007

Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
Seattle, WA | October 19, 2007

Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
Seattle, WA | May 31, 2007


1616 Eastlake Avenue East, Suite 400, Seattle, Washington 98102 office@idri.org  |  P: (206) 381-0883  |  F: (206) 381-3678 © 1993-2014 Privacy Policy
Infectious Disease Research Institute